What Is Alkyl Amines Chemicals Limited?
Alkyl Amines Chemicals Limited is one of India’s leading manufacturers of specialty chemicals, with a dominant position in alkyl amines, ammonia derivatives, and methylamines. Headquartered in Gujarat, the company has been around for over four decades and has built a reputation as a global leader in ethyl amines and several other niche chemical products.
What makes this company stand out is its focus on custom synthesis and tailor-made products. Unlike commodity chemical makers, Alkyl Amines Chemicals works closely with customers in agrochemicals, pharmaceuticals, water treatment, and specialty chemical industries to create specific solutions. This customer-centric approach gives them better pricing power and stickier relationships.
The company operates integrated, asset-heavy plants with strong backward integration, which helps them control costs and maintain quality. With near-zero debt and consistent profitability, Alkyl Amines has earned a spot as a high-quality mid-cap chemical stock that many investors trust for long-term compounding.
Key Products and Revenue Mix
Understanding what Alkyl Amines Chemicals actually sells is crucial for evaluating its business. Here’s how their revenue breaks down:
| Product Category | Revenue Contribution | Key Applications |
|---|---|---|
| Amines | ~50% | Agrochemicals, pharmaceuticals, water treatment |
| Amine Derivatives | ~30% | Specialty chemicals, rubber chemicals |
| Specialty Chemicals | 18-20% | Custom synthesis, contract manufacturing |
The company produces over 100+ products, with ethyl amines being its flagship offering, where it holds a global leadership position. It’s also one of the leading global players in DEHA (Diethyl Hydroxyl Amine), a key water treatment chemical, and a major producer of DMA-HCL and Acetonitrile.
Also Read: Aadhar Housing Finance Share: Complete Guide for Smart Investors in 2026
It feels similar to the way a custom tailor differs from a ready-made garment seller – Alkyl Amines doesn’t just churn out bulk chemicals; they engineer solutions for specific customer needs, which is why their margins tend to be healthier than pure commodity players.
Alkyl Amines Chemicals Share Price Today
As of March 2026, Alkyl Amines Chemicals Share is trading around ₹1,285–₹1,532 on the NSE (ticker: ALKYLAMINE) and BSE (code: 506767), depending on market volatility. The stock has seen some pressure recently, down from its highs of ₹2,200+ in mid-2025, largely due to weaker quarterly results and broader headwinds in the specialty chemicals sector.
Current Valuation Metrics
Here’s a snapshot of where the stock stands fundamentally:
| Metric | Value |
|---|---|
| Market Capitalization | ₹7,000–₹8,000 Cr |
| Current Share Price | ₹1,285–₹1,532 |
| P/E Ratio (TTM) | 43x |
| P/B Ratio | 5.27x |
| Book Value | ₹290.44 |
| EPS (TTM) | ₹35.32 |
| ROE | 13.98% |
| ROCE | 18.67% |
| Dividend Yield | 0.62–0.65% |
| Debt-to-Equity | Near Zero |
The P/E of 43x is on the higher side for a mid-cap chemical stock, which means investors are paying a premium for the company’s quality and consistency. However, this also leaves limited room for error if raw material prices spike or demand weakens further – something we saw play out in Q3 FY26.
I think this valuation makes sense only if you’re investing with a 3–5 year horizon. Short-term traders might find the stock choppy, especially with the current margin pressures.
Q3 FY26 Results: What Happened?
The third quarter of FY26 was a concerning one for Alkyl Amines Chemicals, and it’s important to understand why the stock took a hit. Here’s what the numbers looked like:
Q3 FY26 Financial Performance
| Financial Metric | Q3 FY26 | Q3 FY25 | Change (%) |
|---|---|---|---|
| Revenue from Operations | ₹354.00 Cr | ₹371.20 Cr | -4.6% |
| Total Revenue | ₹362.01 Cr | ₹377.80 Cr | -4.2% |
| Net Profit (PAT) | ₹42.26 Cr | ₹43.76 Cr | -3.4% |
| Operating Margin | 18.97% | ~21% | Significant contraction |
| EPS | ₹8.26 | ₹8.56 | -3.5% |
For the nine months (9M FY26), the picture was similar:
| Nine-Month Metrics | 9M FY26 | 9M FY25 | Change (%) |
|---|---|---|---|
| Revenue from Operations | ₹1,148.94 Cr | ₹1,185.77 Cr | -3.1% |
| Net Profit | ₹134.64 Cr | ₹140.10 Cr | -3.9% |
The substantial margin compression and revenue decline suggest the company is facing real challenges – possibly from weaker demand, pricing pressure from Chinese competitors, or unfavorable contract renewals. Management has acknowledged that FY26 volume growth will remain below the usual 10–15% trajectory due to softer demand conditions.
What worries me slightly is that this isn’t just a one-off bad quarter. The specialty chemicals sector as a whole has been under pressure, with oversupply in certain amines and derivative segments squeezing margins across the board. Alkyl Amines is no exception, even though it’s a quality player.
Why Did Margins Compress?
Several factors contributed to the margin pressure in Q3:
- Raw material volatility: Ammonia and ethanol prices have been fluctuating, impacting input costs
- Pricing pressure from China: Chinese manufacturers have been dumping products at lower prices, forcing Indian players to compete on price
- Weaker demand in agrochemicals: A key end-user industry has shown slower growth, reducing volume uptake
- Product mix shift: Lower-margin products may have contributed more to revenue in this quarter
The good news? The company remains debt-free and has a strong balance sheet, which gives it flexibility to navigate this downturn without major stress.
Business Model and Competitive Advantages
What makes Alkyl Amines Chemicals different from other chemical stocks? Let’s break down its business model and moats.
Integrated Manufacturing Setup
The company operates multiple production facilities in Gujarat with strong backward integration. This means they produce many of their own raw materials and intermediates, reducing dependency on external suppliers and improving cost control. Their main plant has a capacity of around 45,000 tons per year for methyl amines, operating at 80–85% utilization.
This asset-heavy model requires significant capital, but it also creates high entry barriers for new competitors. You can’t just set up an amines plant overnight – it takes years of regulatory approvals, technical expertise, and customer validation.
Customer Stickiness
Alkyl Amines Chemicals doesn’t sell generic products. Much of its revenue comes from custom synthesis and long-term contracts with agrochemical and pharmaceutical companies. Once a customer qualifies Alkyl Amines as a supplier, switching becomes expensive and time-consuming due to regulatory requirements and quality validation processes.
This stickiness shows up in the company’s consistent revenue streams and ability to maintain decent margins even during downturns.
Global Leadership in Niche Segments
The company is a global leader in ethyl amines and one of the top players in DEHA worldwide. This gives them pricing power in these segments and makes them a preferred supplier for multinational corporations looking for reliable Indian manufacturing partners.
Exports contribute a meaningful portion of revenue, though the exact split varies by quarter. This global diversification helps reduce dependence on the domestic market, which can be cyclical.
Debt-Free Balance Sheet
Perhaps the most underrated advantage is the company’s near-zero debt. In a capital-intensive industry where interest costs can eat into profits, Alkyl Amines’ clean balance sheet gives it flexibility to invest in capex, weather downturns, or even pursue acquisitions without financial stress.
It feels similar to how a family with no home loan can sleep better during a recession – the company has options when others don’t.
Alkyl Amines Chemicals vs Competitors
How does Alkyl Amines Chemicals stack up against its peers in the Indian specialty chemicals space? Let’s compare it with some key competitors.
Peer Comparison
| Company | Market Cap (₹ Cr) | P/E Ratio | ROCE | Debt/Equity | Key Focus |
|---|---|---|---|---|---|
| Alkyl Amines Chemicals | 7,000–8,000 | 43x | 18.67% | ~0 | Alkyl amines, custom synthesis |
| Balaji Amines Ltd | 6,000–7,000 | 35–40x | 16–18% | Low | Methyl/ethyl amines |
| Privi Speciality Chemicals | 4,000–5,000 | 30–35x | 15–17% | Low-Moderate | Fragrance ingredients |
| Clean Science & Technology | 12,000–15,000 | 50–55x | 20–22% | 0 | Green chemistry, catalysts |
| Galaxy Surfactants | 5,000–6,000 | 25–30x | 14–16% | Low | Surfactants, personal care |
| Atul Ltd | 45,000+ | 30–35x | 15–17% | Low-Moderate | Diversified chemicals |
Alkyl Amines trades at a premium valuation compared to Balaji Amines (its closest competitor) but offers better ROCE and a cleaner balance sheet. Clean Science & Technology commands an even higher P/E due to its focus on green chemistry and superior margins, but Alkyl Amines holds its own in terms of operational efficiency.
Where Alkyl Amines Chemicals lags slightly is in diversification. Companies like Atul Ltd and Privi Speciality have broader product portfolios, which can cushion them during sector-specific downturns. Alkyl Amines’ heavy reliance on amines and derivatives makes it more cyclical.
Balaji Amines vs Alkyl Amines: Which Is Better?
This is a common question among investors. Both companies are leaders in the amines space, but there are key differences:
- Alkyl Amines has better ROCE, zero debt, and stronger global positioning in ethyl amines
- Balaji Amines trades at a slightly lower valuation and has shown better volume growth in recent quarters
I think Alkyl Amines is the better pick for conservative, long-term investors who prioritize balance sheet strength and consistent returns. Balaji Amines might appeal more to those seeking slightly higher growth at a lower entry valuation.
Dividend History and Shareholder Returns
If you’re an income-focused investor, you’ll want to know about Alkyl Amines’ dividend track record. The company has a consistent dividend policy, though the yield isn’t particularly high.
Recent Dividend Payments
| Date | Dividend Per Share | Type |
|---|---|---|
| May 2025 | ₹10.00 | Final Dividend |
| May 2024 | ₹10.00 | Final Dividend |
| Previous Years | ₹8–₹10 | Annual |
The current dividend yield stands at around 0.62–0.65%, which is modest but in line with most growth-oriented chemical stocks. The company prioritizes reinvestment for growth over high payouts, which makes sense given its expansion plans and capital-efficient model.
For context, a ₹10 dividend on a ₹1,500 share price gives you about 0.67% yield – not enough to live off, but a nice bonus for long-term holders.
What I appreciate is the consistency. Even during tougher quarters, Alkyl Amines has maintained its dividend, signaling management’s confidence in cash flow generation.
Risks Every Investor Should Know
No stock is perfect, and Alkyl Amines comes with its own set of risks. Here’s what you need to watch out for before investing.
Key Risks
- Raw material price volatility: Ammonia and ethanol are key inputs, and their prices can swing wildly based on global energy markets
- Chinese competition: Chinese manufacturers have been aggressively pricing amines and derivatives, squeezing margins for Indian players
- Cyclical demand: Agrochemicals and pharmaceuticals – the company’s main end markets – are cyclical industries. A slowdown here directly impacts volumes
- High valuation: At 43x P/E, the stock leaves little room for error. Any further earnings miss could trigger a sharp correction
- Customer concentration: While the company serves many clients, a few large accounts contribute disproportionately to revenue. Losing one could hurt
- Regulatory risks: Chemical manufacturing is heavily regulated. Any environmental or safety issues could lead to shutdowns or fines
The Q3 FY26 results already showed how quickly things can turn. Revenue and profit both declined, and margins compressed more than expected. If these trends continue into FY27, the stock could face further pressure.
I think the biggest risk right now is valuation. Even a quality company like Alkyl Amines can be a bad investment if you pay too much. At current levels, you’re pricing in a lot of future growth – any stumble and the multiple could contract sharply.
Is Alkyl Amines Chemicals Share a Buy in 2026?
So, should you buy Alkyl Amines Chemicals Share now? Here’s my take based on the data.
Bull Case (Reasons to Buy)
- Quality business: Strong ROCE, zero debt, and consistent profitability over decades
- Global leadership: Dominant position in ethyl amines and DEHA with export opportunities
- Customer stickiness: Custom synthesis model creates long-term relationships
- Sector tailwinds: India’s chemical manufacturing push and China+1 strategy benefit domestic players
- Valuation comfort: Stock is down 30–40% from highs, offering a better entry point than in 2025
Bear Case (Reasons to Wait)
- Weak Q3 FY26: Margin compression and revenue decline signal near-term headwinds
- High P/E: 43x valuation still leaves limited upside if growth doesn’t accelerate
- Cyclical downturn: Specialty chemicals sector is in a downcycle; recovery timing is uncertain
- Chinese pressure: Ongoing price competition from China could keep margins suppressed
Final Verdict
I think Alkyl Amines is a hold for existing investors and a cautious buy for new investors with a 3–5 year horizon. If you’re already holding the stock, there’s no panic-selling reason – the business fundamentals remain intact despite the Q3 miss.
For new investors, I’d suggest a staggered approach. Start with a small position at current levels (₹1,300–₹1,500), and add more if the stock dips below ₹1,200 or if Q4 FY26 shows margin recovery. Don’t go all-in at once – the chemical cycle is still uncertain.
It feels similar to buying a quality house during a market slowdown. You know it’s a good property, but you don’t want to overpay before seeing clear signs of recovery.
How to Track Alkyl Amines Chemicals Share
If you decide to invest or just want to keep an eye on this stock, here’s what to monitor:
Key Metrics to Watch
- Quarterly revenue and volume growth: Look for signs of demand recovery, especially in exports
- Operating margins: Any expansion from the current ~19% would be a positive signal
- Raw material prices: Track ammonia and ethanol trends – lower input costs boost margins
- Capacity utilization: Higher utilization indicates stronger demand and better fixed cost absorption
- Management commentary: Listen to earnings calls for updates on new products, capex plans, and market outlook
Where to Find Updates
- NSE/BSE filings: Official announcements on results, corporate actions, and material events
- Company website: Investor relations section for presentations and concall transcripts
- Financial news platforms: Moneycontrol, Economic Times, and CNBC TV18 for real-time updates
- Brokerage reports: HDFC Securities, Motilal Oswal, and other brokerages periodically publish research notes
I think setting up price alerts on your trading app and subscribing to earnings call summaries is the easiest way to stay on top of this stock without getting overwhelmed by daily noise.
Final Thoughts: Long-Term Potential vs Short-Term Volatility
Alkyl Amines Chemicals is a quality company in a temporarily challenging environment. Its strong balance sheet, global leadership in niche segments, and customer-centric business model make it a compelling long-term hold. However, the near-term outlook remains uncertain due to cyclical headwinds, Chinese competition, and margin pressures.
If you’re investing with a 5-year horizon and can tolerate some volatility, this stock could deliver solid compounding returns of 12–18% annually. But if you’re looking for quick gains or can’t stomach a 20–30% drawdown, you might want to wait for clearer signs of recovery before jumping in.
I think the key is patience. The chemical sector is cyclical by nature, and quality players like Alkyl Amines tend to bounce back stronger after downturns. The question is whether you’re willing to wait for that cycle to turn.
FAQ – Alkyl Amines Chemicals
1. What is the current share price of Alkyl Amines Chemicals?
As of March 2026, Alkyl Amines Chemicals Share is trading between ₹1,285 and ₹1,532 on the NSE (ALKYLAMINE) and BSE (506767), depending on market conditions.
2. Is Alkyl Amines Chemicals a good stock to buy in 2026?
Alkyl Amines is a quality company with strong fundamentals, but it faces near-term headwinds from margin compression and weak demand. It’s suitable for long-term investors (3–5 years) who can tolerate volatility. A staggered buying approach is recommended.
3. What is the share price target for Alkyl Amines Chemicals in 2026?
Analysts project a 2026 price target range of ₹1,600–₹2,462, with some estimates as high as ₹2,382 by year-end if market conditions improve.
4. Why did Alkyl Amines Chemicals’ Q3 FY26 profit decline?
Q3 FY26 net profit fell 3.4% YoY to ₹42.26 Cr due to a 4.6% revenue decline, margin compression from raw material volatility, pricing pressure from Chinese competitors, and softer demand in agrochemicals.
5. Does Alkyl Amines Chemicals pay dividends?
Yes, the company pays an annual dividend of ₹10 per share, giving a dividend yield of approximately 0.62–0.65%.
6. Who are the main competitors of Alkyl Amines Chemicals?
Key competitors include Balaji Amines Ltd, Privi Speciality Chemicals, Clean Science & Technology, Galaxy Surfactants, and Jubilant Ingrevia.
7. What is the P/E ratio of Alkyl Amines Chemicals?
The stock trades at a P/E ratio of approximately 43x (TTM), which is on the higher side for a mid-cap chemical stock.
8. Is Alkyl Amines Chemicals debt-free?
Yes, the company has a near-zero debt balance sheet, which is a significant advantage in the capital-intensive chemical industry.
9. What are the main products of Alkyl Amines Chemicals?
The company manufactures alkyl amines (~50% of revenue), amine derivatives (~30%), and specialty chemicals (18–20%), serving agrochemicals, pharmaceuticals, water treatment, and rubber industries.
10. What is the market cap of Alkyl Amines Chemicals?
The company has a market capitalization of approximately ₹7,000–₹8,000 crore, making it a mid-cap stock in the Indian equity market.
Disclaimer
This article is for informational and educational purposes only and should not be considered as investment advice. Please do your own research or consult a qualified financial advisor before making any investment decisions.
